Skip to main content
OpenTrials
Completed

NCT Number: NCT04902768

Assessment of Patterns of Patient Reported Outcomes in Adults With Congenital Heart Disease - International Study II

This is an international, cross-sectional and descriptive study that aims to investigate differences in patient-reported outcome measures (PROMs) and patient-reported experience measures (PREMs) and that aims to explore the profile and healthcare needs of adults with congenital heart diseases.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Hospital San Juan De Dios De La Plata, Buenos Aires, Argentina

Loading trial locations.

About this study

The research aims of this study are:

  • To further explore differences in a modified selection of patient-reported outcome measures (PROMs) and (as a new addition in APPROACH-IS II) explore differences in patient-reported experience measures (PREMs), by enrolling adults with congenital heart diseases in low, middle, and high income countries and including new potential explanatory variables ("Part 1").
  • To explore the profile and healthcare needs of a subgroup of older adults with congenital heart disease, with a particular focus on investigating the frailty phenotype ("Part 2").

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Diagnosed with congenital heart disease, defined as: "a gross structural abnormality of the heart and/or intra-thoracic great vessels that is actually or potentially of functional significance (including mild, moderate, and complex heart defects)"
  • Aged 18 years of age or older at the moment of study inclusion
  • Diagnosed with congenital heart disease before the age of 10 years
  • Follow-up at an ACHD center or included in a national/regional registry
  • Physical, cognitive, and language abilities to complete self-report questionnaires

Exclusion criteria

  • Prior heart transplantation

Treatment and study plan

This is an observational study, there is no intervention

Other

This is an observational study, there is no intervention. Hence, this is not applicable.

Primary outcomes

  1. Patient-reported health status

    Time frame: Baseline

    This outcome is measured using the shortened version of the RAND-36. Composite physical (PCS) and mental health (MCS) scores are computed. Scores range from 0 (lowest health level) to 100 (highest health level).

  2. Patient-reported health status

    Time frame: Baseline

    This outcome is measured using the Linear Analogue Scale Health Status (LAS HS). Scores range from 0 (worst imaginable health state) to 100 (best imaginable health state).

  3. Patient-reported depressive symptoms

    Time frame: Baseline

    This outcomes is measured using the Patient Health Questionnaire 8. Scores range from 0 to 24. Scores of ≥10 indicate depression.

  4. Patient-reported anxiety symptoms

    Time frame: Baseline

    This outcome is measured using the General Anxiety Disorder 7. Scores range from 0 to 21. Scores of 5, 10, and 15 are taken as cut-off points for mild, moderate and severe anxiety.

  5. Patient-reported quality of life

    Time frame: Baseline

    This outcome is measured using the Linear Analog Scale on Quality of Life (LAS QOL). Scores range from 0 (worst imaginable quality of life) to 100 (best imaginable quality of life).

  6. Patients' perception of providers' autonomy support

    Time frame: Baseline

    This outcome is measured using the modified Health Care Climate Questionnaire (mHCCQ). Each of the 6 items is scored from 1 to 7. Scores are calculated by averaging the individual item scores. Higher average score represents a higher level of perceived autonomy support.

  7. Cognitive functioning

    Time frame: Baseline

    This outcome is measured using the Montreal Cognitive Assessment Screener (MoCA). Scores range from 0 to 30. Scores of <26 indicate cognitive dysfunction.

  8. Frailty phenotype

    Time frame: Baseline

    This outcome is classified using the Fried method (i.e., non-frail (no positive criterion), pre-frail (1 or 2 criteria positive), or frail (when ≥3 criteria are positive).

Secondary outcomes

  1. Patient-reported stigma

    Time frame: Baseline

    This outcome is measured using the Chronic Illness Stigma Scale (CISS). Scores range from 8 to 40. Higher scores indicating higher levels of perceived stigma.

  2. Patient-reported illness identity

    Time frame: Baseline

    This outcome is measured using the Illness Identity Questionnaire (IIQ). The questionnaire consists of a five-item rejection scale, seven-item enrichment scale, five-item acceptance scale and eight-item engulfment scale. A mean score is calculated per subscale. Higher scores indicate more rejection, enrichment, acceptance or engulfment.

  3. Patient-reported empowerment

    Time frame: Baseline

    This outcome is measured using the Gothenburg Empowerment Scale (GES generic v1.1). Scores range from 15 to 75. Higher score reflects a higher level of empowerment.

  4. Patient-reported healthcare utilization

    Time frame: Baseline

    This outcomes was measured using the Patient-Reported Inpatient and outpatient Utilization Survey (PRIUS). Higher numbers indicate more healthcare use.

  5. Patient-reported functional status

    Time frame: Baseline

    This outcome is classified according to the New York Heart Association (NYHA).

  6. Patient-reported social support

    Time frame: Baseline

    This outcomes is measured using the Multidimensional Scale on Perceived Social Support Scale (MSPSS). Scores range from 12 to 84. Higher score indicates greater social support perceived by an individual.

  7. Patient-reported parental involvement

    Time frame: Baseline

    This outcome is measured using an adapted version of the subscale on parents of the Multidimensional Scale on Perceived Social Support. Scores range from 5 to 35. Higher score indicates greater parental support in childhood and adolescence.

  8. Advance care planning

    Time frame: Baseline

    This outcome is measured using a survey developed for APPROACH-IS II by the Steering Committee, based on previous research. A sample question is 'Have you personally written down information about the care you would want in case you become seriously ill in the future?'.

  9. Patient-reported social media to connect with peers

    Time frame: Baseline

    This outcome is measured using a survey developed for APPROACH-IS II by the Steering Committee, based on previous research. A sample question is 'How would you describe your experiences connecting with other people with CHD through social media?'.

  10. Presence and burden of comorbidities

    Time frame: Baseline

    This outcome is measured using the Charlson Comorbidity Index.

  11. Patient-reported socio-demographic variables (eg. age, educational level)

    Time frame: Baseline

    Self-reported

  12. Medical variables by chart review (eg. diagnosis, cardiac surgeries)

    Time frame: Baseline

    This outcome is classified according to the adult congenital heart disease anatomic and physiological (ACHD AP) classification system of Stout and colleagues.

Sponsors and collaborators

Lead sponsor

KU Leuven

Other

Registry information

Official study title

APPROACH-IS II: Assessment of Patterns of Patient Reported Outcomes in Adults With Congenital Heart Disease - International Study II

Acronym: APPROACH-IS II

Important dates

Study start
2019
Primary completion
2022
Study completion
2022
First posted
May 26, 2021
Registry last updated
May 16, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.